Literature DB >> 7840590

In vitro activities of enoxacin, enrofloxacin, sparfloxacin, and ciprofloxacin against Escherichia coli strains isolated from diarrheic lambs and kids.

D Cid1, S Piriz, J A Ruiz-Santa-Quiteria, J Valle, S Garcia, S Vadillo, R de la Fuente.   

Abstract

The in vitro activities of four fluoroquinolone compounds were tested against 92 Escherichia coli strains of ovine and caprine origin under aerobic and anaerobic incubation conditions. The four fluoroquinolones proved to be highly effective against the E. coli isolates tested. When bacteria were cultured anaerobically, at least fourfold increases in the MICs of enoxacin for the strains occurred and no detectable changes in enrofloxacin, sparfloxacin, and ciprofloxacin MICs occurred.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7840590      PMCID： PMC284765          DOI： 10.1128/AAC.38.10.2469

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Effects of norfloxacin on the faecal flora in patients with complicated urinary tract infections.

Authors:  J B Boerema; B J Olthof; H K van Saene
Journal:  Scand J Infect Dis Suppl       Date:  1986

Review 2.  New quinolones and gram-positive bacteria.

Authors:  L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

3.  In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.

Authors:  J Segreti; J A Nelson; L J Goodman; R L Kaplan; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

4.  Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia.

Authors:  D S Rao; A M Parfitt; A R Villanueva; P J Dorman; M Kleerekoper
Journal:  Am J Med       Date:  1987-02       Impact factor: 4.965

5.  In vitro activity of AT-4140 against clinical bacterial isolates.

Authors:  T Kojima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

6.  Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea.

Authors:  H E Pichler; G Diridl; K Stickler; D Wolf
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

7.  Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.

Authors:  C D Ericsson; P C Johnson; H L Dupont; D R Morgan; J A Bitsura; F J de la Cabada
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

8.  Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.

Authors:  H Goossens; P De Mol; H Coignau; J Levy; O Grados; G Ghysels; H Innocent; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

10.  Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal flora.

Authors:  S Pecquet; A Andremont; C Tancrède
Journal:  Antimicrob Agents Chemother       Date:  1986-06       Impact factor: 5.191
View more
  1 in total

1.  In vitro activities of cephalosporins and quinolones against Escherichia coli strains isolated from diarrheic dairy calves.

Authors:  J A Orden; J A Ruiz-Santa-Quiteria; S García; D Cid; R De La Fuente
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.